Development of screening system for searching cellular differentiation-inducing agents by utlizing human salivary cancer cells

开发利用人唾液癌细胞寻找细胞分化诱导剂的筛选系统

基本信息

  • 批准号:
    05557084
  • 负责人:
  • 金额:
    $ 7.04万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

1.Neuron-like cells (HSG-AZAll) with ample neurofilament bundles and endoplasmic reticulum as well as alpha-and beta-chain of tubulin were isolated from human salivary cancer cell line HSG treated with 5-azactidine. This HSG-AZAll cells were found to from neurites and express synaptophysin and neuron-specific enolase in response to dibutyryl cyclic AMP.This indicated that HSG-AZAll cells might be useful for searching cellular differentiation-inducing agents which work via cAMP signal transduction. 2.We have found that the treatment of HSG cells with 5-fluorodeoxyuridine monophosphate results in the differentiation into myoepithelial cells and induciton of apoptosis. 3.We have found that the cultivation of HSG-AZA3 cells with an acinar cell phenotype, which were induced by treatment of HSG cells with 5-azacytidine, in the presence of 3,4-dihydro-6-[3,4-dimethoxybenzoyl)-1-piperazinyl]-2 (1H) -quinolnone (vesnarinone) results in the differentiation into chondrocytes.In addition, it has b … More een found that the treatment of HSG-AZA3 cells with 22-oxa-1alpha, 25-dihydroxyvitamin D_3 causes the differentiation into osteoblasts. 4.We have found that the treatment of HSG cells with etoposide, an inhibitor of DNA topoisomerase II,results in the induction of cells with a smooth muscle cell phenotype, such as expression of alpha-smooth muscle actin and myofilaments, as well as in the induction of apoptosis. 5.When adenoid squamous carcinoma-forming cells (TYS) , derived from human minor salivary gland present in the oral cavity, was treated with 5-fluorouracil or vesnarinone, it has been found that the induction of apoptosis and differentiation into acinar cells occurs in the treated cells. 6.The treatment with 22-oxa-1alpha, 25 (OH) _2D_3 of HSG-AZA3 cells grown as xenografts in nude mice resulted in the marked growth inhibition of tumors, in which bone formation and bone remodeling were detected. 7.When TYS nude mouse tumors were treated with vesnarinone, significant suppression of tumor growth as well as differentiation into both keratinocytes and acinar cells were detected in the treated tumors. Less
1。具有充足的神经丝束和内质网状细胞(HSG-ASGALL),以及从人类唾液癌细胞系HSG的α链,并从5-氮杂氨酸中治疗。突触素和神经元特异性酶响应对脱晶环状AMP的反应。这表明通过cAMP信号转导处理HSG细胞的细胞差异剂可能是使用5-氟二磷酸酯单磷酸盐的细胞差异。 3。我们发现,在存在3,4-二氢-6- [3,4-二甲氧基苯甲酰氮的存在下,用腺泡细胞表型-Azytidine培养HSG-AZA3细胞-2-dimethoxybenzoyl)-2 -2-Piperaziny(1H)-Quinolnone ation-quinolnone ation ation此外,它还具有B…更多的EEN发现HSG-AZA3细胞用22-oxa-1alpha E的治疗发现了用依ETOPOSIS(DNA拓扑异构酶II的过度蛋白酶)处理HSG细胞,从而导致与细胞指示的DNA拓扑异构酶II平滑的肌肉细胞表型,例如α-光滑肌肉肌动蛋白的表达和肌细胞肌细胞的凋亡。 OXA-1Alpha,25(OH)_2D_3的裸鼠中的HSG-AZA3 cenograpts导致明显​​的肿瘤抑制作用。角质形成细胞和腺泡细胞都在较少的肿瘤中检测到。

项目成果

期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
東 雅之: "SV40 不死化正常ヒト唾液腺細胞における野生型P53の発現" 日本口腔科学会雑誌. 43. 580-589 (1994)
Masayuki Higashi:“野生型 P53 在 SV40 永生化正常人唾液腺细胞中的表达”日本口腔医学会杂志 43. 580-589 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
東雅之: "SV40不死化正常ヒト唾液腺細胞における野生型P53の発現" 日本口腔科学会雑誌. 43. 580-589 (1994)
Masayuki Azuma:“野生型 P53 在 SV40 永生化正常人唾液腺细胞中的表达”日本口腔医学会杂志 43. 580-589 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hideo Yoshida: "Emergence of a smooth muscle cell phenotype and apoptosis by treatment with etoposide,an inhibitor of DNA topoisomerase II,in a neoplastic human salivary intercalated duct cell line" Cancer Journal. 6. 220-228 (1993)
Hideo Yoshida:“用依托泊苷(一种 DNA 拓扑异构酶 II 抑制剂)治疗肿瘤性人唾液闰管细胞系时出现平滑肌细胞表型和凋亡”《癌症杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
佐藤光信: "唾液腺腫瘍の分化誘導療法" 癌と化学療法. 20. 1028-1036 (1993)
Mitsunobu Sato:“唾液腺肿瘤的分化诱导疗法”《癌症与化疗》20。1028-1036(1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mitsunobu Sato: "Induction of differentiation and apoptosis, and Le^Y antigen expression by treatment with 3,4-dihydro-6-〔4-(3,4-dimethoxybenzoy1)-1-piperaziny1〕-2(1H)-quinolinone(vesnarinone)in a human salivary cancer cell line" Acta Histochem.Cytochem.
Mitsunobu Sato:“用 3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基 1)-1-哌嗪基 1]-2(1H)-喹啉酮处理诱导分化和凋亡,以及 Le^Y 抗原表达( vesnarinone)在人唾液癌细胞系中的作用“Acta Histochem.Cytochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATO Mitsunobu其他文献

SATO Mitsunobu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATO Mitsunobu', 18)}}的其他基金

Syntheses of apatite via Ca complexes of amino acids involved innon-collagen protein
通过参与非胶原蛋白的氨基酸的 Ca 络合物合成磷灰石
  • 批准号:
    22550183
  • 财政年份:
    2010
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Toll-like receptor 4 signaling : Enhancement of therapeutic effect of anti-cancer drugs and radiation in oral Cancer
Toll样受体4信号传导:增强口腔癌的抗癌药物和放射治疗效果
  • 批准号:
    14207090
  • 财政年份:
    2002
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of the therapy for oral cancer by transduction of iNOS gene in combination with radiotherapy
iNOS基因转导联合放疗治疗口腔癌的进展
  • 批准号:
    12557176
  • 财政年份:
    2000
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on differentiation and apoptosis-inducing therapy for head and neck cancer by vesnarinone
维纳里酮诱导头颈癌分化和凋亡的研究
  • 批准号:
    10307051
  • 财政年份:
    1998
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Lipoteichoic acid : Augmentation of the therapeutic effect of radiation and 5-fluorouracil in head and neck cancer
脂磷壁酸:增强放射线和5-氟尿嘧啶对头颈癌的治疗效果
  • 批准号:
    09557170
  • 财政年份:
    1997
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Detection of Novel Drug Receptor and Mechanism of Induction of Differentiation and Apoptosis in Human Salivary Cancer Cells
人唾液癌细胞新型药物受体的检测及诱导分化和凋亡的机制
  • 批准号:
    06404072
  • 财政年份:
    1994
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study of Differentiation Therapy for Salivary Gland Cancer
唾液腺癌的分化治疗研究
  • 批准号:
    03454467
  • 财政年份:
    1991
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Development of Multi-functional Ligands for Application of Metal Complexes
金属配合物应用多功能配体的开发
  • 批准号:
    03650687
  • 财政年份:
    1991
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Local Immunotherapy of Oral Cancer with LAK Cells and Interleukin 2
LAK 细胞和白细胞介素 2 治疗口腔癌的局部免疫疗法
  • 批准号:
    63870080
  • 财政年份:
    1988
  • 资助金额:
    $ 7.04万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似国自然基金

神经元诱导剂促进髓母细胞瘤分化抑制恶性增殖
  • 批准号:
    82303646
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
循时自控释药物共递送系统用于乳腺癌的联合治疗研究
  • 批准号:
    81673381
  • 批准年份:
    2016
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
基于人羊膜间充质干细胞向成骨、软骨细胞定向分化的真菌来源天然小分子诱导剂发现及调控机制
  • 批准号:
    81660363
  • 批准年份:
    2016
  • 资助金额:
    37.0 万元
  • 项目类别:
    地区科学基金项目
基于鸡ESCs分化为雄性生殖细胞调控关键基因和信号通路筛选诱导剂的研究
  • 批准号:
    31272429
  • 批准年份:
    2012
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
细胞分化诱导剂福司可林促癌细胞逆转机理的研究
  • 批准号:
    39570178
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    面上项目

相似海外基金

2010 Glycolipid & Sphingolipid Biology Gordon Research Conference
2010糖脂
  • 批准号:
    7800051
  • 财政年份:
    2009
  • 资助金额:
    $ 7.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了